In particular, MHC class-І-restricted peptides (i.e., CTL epitopes) recognized by CD8+ CTLs play a key role in attacking cancer cells by promoting the activation and proliferation of antigen-specific CTLs22. The gene discussed is CD8A; the disease is cancer.